NASDAQ:WBA

Walgreens Boots Alliance Earnings Date, Estimates, & History

$49.18

+0.79 (+1.63 %)

(As of 10/21/2021 10:34 AM ET)

Add

Compare

Today's Range

$48.30

▼

$49.19

50-Day Range

$46.69

▼

$51.78

52-Week Range

$33.36

▼

$57.05

Volume78,809 shs

Average Volume5.87 million shs

Market Capitalization$42.57 billion

P/E Ratio18.63

Dividend Yield3.98%

Beta0.49

Upcoming
Earnings Date
Jan. 6
Estimated

Actual EPS
(Oct. 14)
$1.17
Beat By $0.15

Consensus EPS
(Oct. 14)
$1.02

Last Year's Q4 EPS
(10/15/2020)
$1.02

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

Walgreens Boots Alliance Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Walgreens Boots Alliance Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Walgreens Boots Alliance (NASDAQ:WBA) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2021	3	$1.03	$1.30	$1.12
Q2 2021	3	$1.00	$1.49	$1.21
Q3 2021	3	$1.05	$1.43	$1.23
Q4 2021	3	$0.98	$1.38	$1.14
FY 2021	12	$4.06	$5.60	$4.70
Q1 2022	1	$1.24	$1.24	$1.24
Q2 2022	1	$1.35	$1.35	$1.35
Q3 2022	1	$1.24	$1.24	$1.24
Q4 2022	1	$1.22	$1.22	$1.22
FY 2022	4	$5.05	$5.05		$5.05

WBA Earnings Information

Walgreens Boots Alliance last posted its earnings data on October 14th, 2021. The pharmacy operator reported $1.17 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.15. The firm earned $34.26 billion during the quarter, compared to analyst estimates of $33.39 billion. Its revenue for the quarter was up 12.8% on a year-over-year basis. Walgreens Boots Alliance has generated $4.74 earnings per share over the last year ($2.64 diluted earnings per share) and currently has a price-to-earnings ratio of 18.6. Earnings for Walgreens Boots Alliance are expected to grow by 7.58% in the coming year, from $4.75 to $5.11 per share. Walgreens Boots Alliance has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 6th, 2022 based off prior year's report dates.

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
1/6/2022 (Estimated)
10/14/2021	8/31/2021	$1.02	$1.17	+$0.15	$1.62	$33.39 billion	$34.26 billion
6/30/2021	5/31/2021	$1.17	$1.38	+$0.21	$1.64	$33.47 billion	$34.03 billion
3/30/2021	2/28/2021	$1.10	$1.40	+$0.30	$1.61	$36.16 billion	$32.78 billion
1/6/2021	11/30/2020	$1.03	$1.22	+$0.19	$2.80	$35.01 billion	$36.31 billion
10/15/2020	8/31/2020	$0.96	$1.02	+$0.06	$1.61	$34.36 billion	$34.75 billion
7/9/2020	5/31/2020	$1.10	$0.83	($0.27)	$3.61	$34.32 billion	$34.63 billion
4/2/2020	2/29/2020	$1.46	$1.52	+$0.06	$1.97	$35.24 billion	$35.82 billion
1/8/2020	11/30/2019	$1.40	$1.37	($0.03)	$1.79	$34.45 billion	$34.34 billion
10/28/2019	Q4 2019	$1.41	$1.43	+$0.02	$2.11	$33.88 billion	$33.95 billion
6/27/2019	Q3	$1.42	$1.47	+$0.05	$1.81	$34.52 billion	$34.59 billion

4/2/2019	2/28/2019	$1.70	$1.64	($0.06)	$2.04	$34.57 billion	$34.53 billion
12/20/2018	Q1 2019	$1.43	$1.46	+$0.03	$1.74	$33.90 billion	$33.79 billion
10/11/2018	8/31/2018	$1.45	$1.48	+$0.03	$1.41	$33.64 billion	$33.44 billion
6/28/2018	Q3 2018	$1.47	$1.53	+$0.06	$1.71	$34.15 billion	$34.33 billion
3/28/2018	Q2 2018	$1.55	$1.73	+$0.18	$2.10	$32.20 billion	$33.02 billion
1/4/2018	Q1 2018	$1.27	$1.28	+$0.01	$1.75	$30.39 billion	$30.74 billion
10/25/2017	Q4 2017	$1.21	$1.31	+$0.10	$1.86	$29.93 billion	$30.15 billion
6/29/2017	Q3 2017	$1.30	$1.33	+$0.03	$1.59	$29.72 billion	$30.12 billion
4/5/2017	Q2 2017	$1.36	$1.36		$1.74	$30.17 billion	$29.45 billion
1/5/2017	Q1 2017	$1.09	$1.10	+$0.01	$1.23	$29.37 billion	$28.50 billion
10/20/2016	Q4 2016	$0.99	$1.07	+$0.08	$1.19	$29.06 billion	$28.60 billion
7/6/2016	Q3 2016	$1.14	$1.18	+$0.04	$1.35	$29.93 billion	$29.50 billion
4/5/2016	Q2 2016	$1.27	$1.31	+$0.04	$1.77	$30.72 billion	$30.18 billion
1/7/2016	Q1 2016	$0.97	$1.03	+$0.06	$1.05	$29.24 billion	$29.00 billion
10/28/2015	Q4 2015	$0.81	$0.88	+$0.07	$1.74	$28.45 billion	$28.50 billion
7/9/2015	Q3 2015	$0.87	$1.02	+$0.15	$0.86	$30.28 billion	$28.80 billion
4/9/2015	Q2 2015	$0.94	$1.18	+$0.24	$0.43	$27.27 billion	$26.60 billion
12/23/2014	Q1 2015	$0.74	$0.81	+$0.07	$0.77	$19.43 billion	$19.55 billion
9/30/2014	Q4 2014	$0.74	$0.74		$1.73	$19.02 billion	$19.06 billion
6/24/2014	Q3 2014	$0.94	$0.91	($0.03)	$1.07	$19.33 billion	$19.40 billion
3/25/2014	Q2 2014	$0.93	$0.91	($0.02)	$1.04	$19.61 billion	$19.60 billion
12/20/2013	Q1 2014	$0.72	$0.72		$0.72	$17.98 billion	$18.30 billion
10/1/2013	Q4 2013	$0.73	$0.73		$0.77	$17.95 billion	$17.90 billion
6/25/2013	Q3 2013	$0.90	$0.85	($0.05)	$1.05	$18.44 billion	$18.30 billion
3/19/2013	Q2 2013	$0.95	$0.96	+$0.01	$1.13	$18.72 billion	$18.65 billion
12/21/2012	Q1 2013	$0.70	$0.58	($0.12)		$17.50 billion	$17.32 billion
9/28/2012	Q412	$0.56	$0.63	+$0.07		$17.16 billion	$17.10 billion
6/19/2012		$0.63	$0.62	($0.01)
3/27/2012		$0.77	$0.78	+$0.01
12/21/2011		$0.67	$0.63	($0.04)
9/27/2011		$0.56	$0.57	+$0.01
6/21/2011		$0.63	$0.66	+$0.03
3/22/2011		$0.80	$0.80
12/22/2010		$0.54	$0.62	+$0.08		$17.31 billion	$17.34 billion
9/28/2010	Q4 2010	$0.44	$0.49	+$0.05	$0.49
6/22/2010	Q3 2010	$0.57	$0.47	($0.10)	$0.47
3/23/2010	Q2 2010	$0.71	$0.68	($0.03)	$0.68
12/21/2009	Q1 2010	$0.48	$0.49	+$0.01	$0.49
9/29/2009	Q4 2009	$0.39	$0.44	+$0.05	$0.44
6/22/2009	Q3 2009	$0.56	$0.53	($0.03)	$0.53
3/23/2009	Q2 2009	$0.67	$0.65	($0.02)	$0.65
12/22/2008	Q1 2009	$0.46	$0.41	($0.05)	$0.41
9/29/2008	Q4 2008	$0.45	$0.45		$0.45
6/23/2008	Q3 2008	$0.59	$0.58	($0.01)	$0.58
3/24/2008	Q2 2008	$0.67	$0.69	+$0.02	$0.69

(Earnings results data provided by Zacks Investment Research)

Walgreens Boots Alliance (NASDAQ:WBA) Earnings Frequently Asked Questions

When is Walgreens Boots Alliance's earnings date?: Walgreens Boots Alliance has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, January 6th, 2022 based off last year's report dates. Learn more on WBA's earnings history
Did Walgreens Boots Alliance beat their earnings estimates last quarter?: In the previous quarter, Walgreens Boots Alliance (NASDAQ:WBA) reported $1.17 earnings per share (EPS) to beat the analysts' consensus estimate of $1.02 by $0.15. Learn more on WBA's earnings details
How can I listen to Walgreens Boots Alliance's earnings conference call?: The conference call for Walgreens Boots Alliance's latest earnings report can be listened to online. Listen to Conference Call
How can I read Walgreens Boots Alliance's conference call transcript?: The conference call transcript for Walgreens Boots Alliance's latest earnings report can be read online. Read Transcript

How much revenue does Walgreens Boots Alliance generate each year?: Walgreens Boots Alliance (NASDAQ:WBA) has a recorded annual revenue of $139.54 billion.
How much profit does Walgreens Boots Alliance generate each year?: Walgreens Boots Alliance (NASDAQ:WBA) has a recorded net income of $456 million. WBA has generated $4.74 earnings per share over the last four quarters.
What is Walgreens Boots Alliance's price-to-earnings ratio?: Walgreens Boots Alliance (NASDAQ:WBA) has a trailing price-to-earnings ratio of 18.33 and a forward price-to-earnings ratio of 10.19. The price/earnings-to-growth ratio is 1.41.
What is Walgreens Boots Alliance's EPS forecast for next year?: Walgreens Boots Alliance's earnings are expected to grow from $4.75 per share to $5.11 per share in the next year, which is a 7.58% increase.

This page was last updated on 10/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.